TAROF: FDA Approves Generic Penlac(R) Nail Lacquer and Claritin(R) Syrup (Nasdaq)
Taro Pharmaceutical Industries Ltd. (TAROF) received approvals from the FDA for its Abbreviated New Drug Application ("ANDA") for Ciclopirox Topical Solution, 8% (Nail Lacquer), and its Supplemental ANDA for Loratadine Syrup (Oral Suspension), a 5 mg/5 mL in a grape flavored formulation and over-the-counter product.

Congress Approves Drug Safety Changes (WebMD)
Congress passed a package of new drug safety rules giving the FDA more power to regulate drug companies, their products, and their advertisements.

AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II (ThomasNet)
MINNEAPOLIS, Aug. 24 / / -- AGA Medical Corporation ("AGA") announced today that it has received U.S. Food and Drug Administration (FDA) and European CE Mark approvals for the AMPLATZER Vascular Plug II ("vascular plug II"). The AMPLATZER Vascular Plug II expands the AGA family of occlusion devices designed to embolize, or close blood vessel and blood vessel malformations in the peripheral ...